Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Clinical pharmacology and differential cognitive efficacy of estrogen preparations.

Gleason CE, Carlsson CM, Johnson S, Atwood C, Asthana S.

Ann N Y Acad Sci. 2005 Jun;1052:93-115. Review.

PMID:
16024754
3.

Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review.

Sherwin BB, Henry JF.

Front Neuroendocrinol. 2008 Jan;29(1):88-113. Epub 2007 Oct 1. Review.

PMID:
17980408
4.

Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?

Sherwin BB.

Ann N Y Acad Sci. 2005 Jun;1052:3-10. Review.

PMID:
16024746
6.

Neuroprotective effects of female sex steroids in humans: current controversies and future directions.

Gleason CE, Cholerton B, Carlsson CM, Johnson SC, Asthana S.

Cell Mol Life Sci. 2005 Feb;62(3):299-312. Review.

PMID:
15723166
7.

Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

Banks E, Canfell K.

Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.

PMID:
19468078
8.

Estrogen and progestogen effect on venous thromboembolism in menopausal women.

Archer DF, Oger E.

Climacteric. 2012 Jun;15(3):235-40. doi: 10.3109/13697137.2012.664401. Review.

PMID:
22612609
9.
10.

Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen.

Modena MG, Bursi F, Fantini G, Cagnacci A, Carbonieri A, Fortuna A, Rossi R.

Am J Med. 2002 Sep;113(4):331-4. No abstract available.

PMID:
12361820
11.

WHI and WHIMS follow-up and human studies of soy isoflavones on cognition.

Zhao L, Brinton RD.

Expert Rev Neurother. 2007 Nov;7(11):1549-64. Review.

PMID:
17997703
12.

The pharmacokinetics and efficacy of different estrogens are not equivalent.

Ansbacher R.

Am J Obstet Gynecol. 2001 Feb;184(3):255-63. Review.

PMID:
11228470
13.

Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials.

Anderer P, Saletu B, Gruber D, Linzmayer L, Semlitsch HV, Saletu-Zyhlarz G, Brandst├Ątter N, Metka M, Huber J.

Maturitas. 2005 Jul 16;51(3):254-69.

PMID:
15978969
14.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
15.

Safety and benefit considerations for menopausal hormone therapy.

Pickar JH, Archer DF, Kagan R, Pinkerton JV, Taylor HS.

Expert Opin Drug Saf. 2017 Aug;16(8):941-954. doi: 10.1080/14740338.2017.1343298. Epub 2017 Jun 30. Review.

PMID:
28664754
16.

Postmenopausal hormone therapy: new questions and the case for new clinical trials.

Manson JE, Bassuk SS, Harman SM, Brinton EA, Cedars MI, Lobo R, Merriam GR, Miller VM, Naftolin F, Santoro N.

Menopause. 2006 Jan-Feb;13(1):139-47.

PMID:
16607110
17.

Estrogen effects on the hippocampus and frontal lobes.

Maki PM.

Int J Fertil Womens Med. 2005 Mar-Apr;50(2):67-71. Review.

PMID:
16334413
18.

Estrogen and Alzheimer's disease: the story so far.

Cholerton B, Gleason CE, Baker LD, Asthana S.

Drugs Aging. 2002;19(6):405-27. Review.

PMID:
12149049
19.

Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.

Richman S, Edusa V, Fadiel A, Naftolin F.

Menopause. 2006 Jan-Feb;13(1):148-55.

PMID:
16607111

Supplemental Content

Support Center